Format

Send to

Choose Destination
Clin Lung Cancer. 2003 May;4(6):336-8.

Erlotinib (OSI-774, Tarceva), a selective epidermal growth factor receptor tyrosine kinase inhibitor, in combination with chemotherapy for advanced non-small-cell lung cancer.

PMID:
14599299

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center